期刊名称：CURRENT VASCULAR PHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.
Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider ¡®research-based¡¯ reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.
Debates will also be encouraged in the correspondence section of this journal.
Indexed in
Chemical Abstracts, EMBASE, MEDLINE
Instructions to Authors
Instructions for Authors
Manuscripts and letters should be submitted to the editorial office at the following address:
Dimitri P. Mikhailidis
MD, FACB, FACA, FFPM, FRCP, FRC Path
Editor-in-Chief
Academic Head of Dept.
Dept. of Clinical Biochemistry
(Vascular Disease Prevention Clinics)
Royal Free Hospital
Royal Free and University College School of Medicine
(University of London)
Pond Street, London NW3 2QG
UK
Tel: 0044 (0) 20 7830 2258
Fax: 0044 (0) 20 7830 2235
E-mail: MIKHAILIDIS@aol.com & mikhailidis@hotmail.com
Unless invited to provide a review it is preferable to send a brief outline of any text you propose to submit to the Editor-in-Chief. Topic headers will be sufficient. The approximate date of submission of your review should also be included. The text must be written in the Vancouver style throughout the manuscript.
There is no specified word count for the reviews, however, the authors must cover a topic in detail (suggested length of the text is 20-30 A-4 pages that will convert to 15-20 pages in publication). All submitted manuscripts should be typed in double spacing throughout on A-4 or US Letter (8.5x11 inches) paper. Dot matrix print or any print that is difficult to read is unacceptable. Two copies of the manuscript must accompany the original (along with a computer disk) should be sent to the journal's Editorial Office. All pages should be numbered. Abbreviations should be defined the first time they are used in the manuscript and a list of abbreviations used should also be provided.
Manuscript Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may further be subdivided according to the areas to be discussed.
The Acknowledgement (if any) and Reference sections should follow later. The first page should contain the title, the authors¡¯ names and the affiliation(s) with an asterisk at the end of the name of the principal author.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Abstract: The abstract should not exceed 250 words and it should condense the essential features of the review article, with the focus on the major advances in the field.
Key Words: Authors must supply up to eight key words along with their manuscript.
Text: The main text should begin on a separate page and it may be subdivided but not into the separate sections. The review article should mention any previous important reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the Reference section.
Tables:
- Data Tables should be submitted in Microsoft Excel or in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
- Tables should not contain vertical rules.
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
- If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures / Illustrations:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Current Vascular Pharmacology.
Editorial Requirements:
The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic print of the original for publication.
- Do not submit photocopies. (Hardcopy submission requirement).
- Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
- Good quality of hardcopy originals are a requirement.
- Figures should be referred to as ¡°Fig. (1)¡±, ¡°Fig. (2)¡± etc. in the text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete set of artwork and photographs.
Technical Details:
- Figures should be provided on high quality, white, smooth opaque paper. (Hardcopy requirement).
Format & Resolution:
- The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations must fit a single or double column format on the journal page, according to the following guideline below:
|
HEIGHT |
WIDTH |
|
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) |
|
DOUBLE COLUMN |
24 cm (max) |
18 cm (max) |
- Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
- Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional effect to the illustration.
- Symbols and lettering in the illustration should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
Photographs:
Submit high-contrast prints that are of single- or double-column width so that they will not have to be reduced when printed. Negatives are not acceptable. However, in case of hardcopy submission, color illustrations and plates can be published from 35 mm color slides.
Structures: Structures should be presented separately, drawn using a suitable graphics program (e.g. ChemDraw) and printed with a laser printer. The structures should fit into a width of 8 cm (for structures to be inserted within single column widths) or a width of 18 cm (for structures or schemes to be inserted in double column widths).
References: References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section. All references must be complete and accurate. Online citations should include date of access. Journal titles should conform to the present Index Medicus abbreviations. It is necessary to list all authors if the total number of authors is 6 or less and for more than six authors use et al. References should be listed in the following Vancouver style:
Typical Paper Reference:
Boehm M, Nabel EG. Angiotensin-converting enzyme 2--a new cardiac regulator. N Engl J Med 2002; 347: 1795-7.
SoRelle R. Long reach of the N-terminal of B-type natriuretic peptide. Circulation 2002; 106: 9059-63.
Typical Chapter Reference:
Stevenson WG, Friedman PL. In: Hennekens CH Ed, Clinical trials in cardiovascular disease. Philadelphia, WB Saunders Co. 1999; 217-30.
Abstracts, unpublished data and personal communications (which can only be included if the permission has been obtained) should not be given in the reference section but they may be mentioned in the text with details provided as footnotes.
Manuscript Submission: Two copies of the manuscript must accompany the original along with the soft copy of the manuscript on a computer floppy disk(s) in MS Word file format (or created in any other well-known word processing software) should be submitted. To achieve rapid publication authors are encouraged to e-mail or fax their submission to the appropriate editorial office (see above) at the same time that they mail the manuscript. For even faster publication, authors are encouraged to submit their entire manuscript via Bentham¡¯s online submission service (see below). Authors must provide their full address, telephone and Fax numbers with E-Mail address with all submissions.
For expedient and speedy reviewing of author's manuscripts, authors are strongly advised to include the PDF file of their manuscript on a floppy or zip disk, into the mailing material. At the same time the package is mailed, please also send by e-mail a copy of the PDF file of the manuscript to the editorial office.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts and manuscripts, an online submission and tracking service via Internet is being offered. Once the Editor-in-Chief of the journal has accepted your abstract, we would prefer that you submit your full manuscript online via our online submission service available at www.bentham-mps.org
For online submission, please provide your complete manuscript in the form of a single zipped folder containing all the material (main text, figures/ illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files and a PDF version of the entire manuscript with all the figures/ illustrations / tables / chemical structures etc., embedded in the text exactly in the manner as they should appear in printing.
Authors are required to proofread the PDF version of their manuscript before submission. The article will be published exactly as received and the Publishers will not be responsible for any error occurring in the manuscript in this regard.
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org or by FTP submission at www.bentham-ftp.org
You may, however, still submit your abstracts and manuscripts through conventional surface mail.
Page Charges: No page charges will be levied to authors.
Language Editing: Manuscripts submitted containing many English typographical errors will not be published. Authors from non-English language countries are advised to use the services of our professional language editing department prior to submitting their manuscript to the Journal. Please contact Bentham Publishing Services www.bentham.org/bps for a language editing quote at e-mail: bps@bentham.org stating the total number of words of the article to be edited.
Proofs: Authors are sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Authors will be charged for excessive changes made at the page proof stage.
Reprints: Each first named author will receive by e-mail a free copy of their article as a PDF file. The PDF file is a watermarked version of the published article which is exclusively for the author's own use and may not be copied or distributed. Reprints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org
Bentham Open Access: Accepted articles can be published online for an immediate free open access for all to view. Open access publishing provides the maximum dissemination of the article to the largest audience. Authors must pay for this service. For more information please contact us at e-mail: openaccess@bentham.org
Reviewing and Promptness of Publication: All papers submitted for publication will be immediately subjected to editorial scrutiny, usually in consultation with members of the Editorial Advisory Board. Every effort will be made to assess the papers quickly. The papers will be typeset and the proofs dispatched to the authors normally within 4 weeks of their acceptance.
Copyright: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication
Editorial Board
Editor in Chief:
Dimitri P. Mikhailidis
Academic Head of Dept.
Dept. of Clinical Biochemistry
(Vascular Disease Prevention Clinics)
Royal Free Hospital
Royal Free and University College School of Medicine
(University of London)
Pond Street , London NW3 2QG
UK
Tel: 0044 (0) 20 7830 2258
Fax: 0044 (0) 20 7830 2235
E-mail: MIKHAILIDIS@aol.com & mikhailidis@hotmail.com
Co-Editors:
M.R. Dashwood
Department of Clinical Biochemistry
Royal Free Hospital, London
UK
R. Wray
Department of Cardiology
Conquest Hospital, East Sussex
UK
A.S. Wierzbicki
Department of Chemical Pathology
St. Thomas' Hospital, London
UK
Regional Editor (Australia & New Zealand):
Greg Dusting
Bernard O'Brien Institute of Microsurgery
University of Melbourne
Victoria
Australia
Regional Editor (Japan):
Uichi Ikeda
Department of Organ Regeneration
Shinshu University Graduate School of Medicine
Matsumoto
Japan
Regional Editor (USA):
Pal Pacher
National Institute of Health, NIAAA, DICBR
Laboratory of Physiologic Studies
Rockville, MD
USA
Editorial Advisory Board:
N. Al-Saady (St. George¡¯s Hospital Medical School, London, UK)
M. Autieri (Temple Univ. Sch. of Med., Philadelphia, PA, USA)
B. Battistini (Pharmacol. Laval Hospt. Res. Ctr. QC, Canada)
A. Chester (Harefield Hospital, London, UK)
M. Elisaf (University of Ioannina, Ioannina, Greece)
A. Ferro (King's College London, London, UK)
J.Y. Jeremy (University of Bristol, London, UK)
T. Johns (Berlex Biosciences, Richmond, CA, USA)
A. Loesch (University College London, London, UK)
Q. Ma (University at Buffalo, Buffalo, NY, USA)
M. Marber (Rayne Institute, London, UK)
H.F. McIntyre (Conquest Hospital, East Sussex, UK)
K. M¨¹nter (BAYER AG, Wuppertal, Germany)
J.B. Pittard (St. Peters Hospital, Surrey, UK)
J.M. Ritter (St. Thomas' Hospital, London, UK)
T.M. Schiele (University of Munich, Munich, Germany)
A.M. Seifalian (Royal Free Hospital, London, UK)
S. Shaw (University of Bern, Bern, Switzerland)
L. Sobrevia (Pontificia Universidad Catolica de Chile, Santiago, Chile)
C. Szabo (Inotek pharma, Beverly, MA, USA)
T. Tatlisumak (Helsinki Univ. Central Hospt., Helsinki, Finland)
Q. Xu (St. George's Hospital Medical School, London, UK)
| 
